"Researchers at UCLA have developed a molecular compound that improves balance and coordination in mice with early stage Parkinson’s disease. Further, the drug, called CLR01, reduced the amount of a toxic protein in the brain that is thought to be one of the prime culprits..." Continue reading.
Balance and movement improved in animal model of Parkinson’s disease (University of California, Los Angeles)
16 June, 2017
Communication Health Assistants